MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS

Clinical trials for MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS trials appear

Sign up with your email to follow new studies for MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for multiple myeloma: early trial of HDP-101 begins in china

Disease control Recruiting now

This early-stage study tests a new drug called HDP-101 in 15 Chinese patients with multiple myeloma, a type of blood cancer. The goal is to find a safe dose and see if the drug can shrink tumors. Participants must have tried other treatments first.

Matched conditions: MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS

Phase: PHASE1 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 13, 2026 16:01 UTC

MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS

Get alerted when new MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS trials appear

New hope for multiple myeloma: early trial of HDP-101 begins in china